New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene therapy ...

New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene therapy ...

Making money online with video isn't only for people with fancy gear or editing skills. With a Free AI Video Generator like InVideo AI, you can go from an ...

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States College of Health Solutions, Arizona State University, Phoenix, United States ...

The University of West Florida has been awarded a five-year, $555,000 National Institutes of Health R25 Research Education Grant from the Nat ...

Vertex Pharmaceuticals Incorporated today announced positive data from a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

SAN DIEGO - Boundless Bio (NASDAQ:BOLD) reported a fourth quarter loss of -$0.58 per share, beating analyst estimates of -$1.16 per share, as the clinical-stage oncology company opened enrollment for ...

ITAT Panaji refused to condone an 803-day delay in filing appeals against TDS default orders. The Tribunal held that the appellant failed to provide a credible explanation and therefore dismissed the ...

The exam was conducted today, March 9. Download the question paper PDF, check the detailed exam analysis, and review the ...